Your browser doesn't support javascript.
loading
Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin, Marie-Emilie; Van Der Made, Thomas K; Pijpers, Ils; Dillen, Lieve; Kunze, Annett; Jonkers, Sophie; Steemans, Kathleen; Tuytelaars, An; Jacobs, Frank; Monshouwer, Mario; Scotcher, Daniel; Rostami-Hodjegan, Amin; Galetin, Aleksandra; Snoeys, Jan.
Afiliación
  • Willemin ME; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium. mwille15@its.jnj.com.
  • Van Der Made TK; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Pijpers I; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Dillen L; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Kunze A; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Jonkers S; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Steemans K; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Tuytelaars A; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Jacobs F; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Monshouwer M; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Scotcher D; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Galetin A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Snoeys J; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
Clin Pharmacokinet ; 60(9): 1187-1199, 2021 09.
Article en En | MEDLINE | ID: mdl-33840062
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Proteína 1 de Transporte de Anión Orgánico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Pharmacokinet Año: 2021 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Proteína 1 de Transporte de Anión Orgánico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Pharmacokinet Año: 2021 Tipo del documento: Article País de afiliación: Bélgica